Topic hub
Vaccine Trial
Oxford University launches first human trial of Bundibugyo Ebola vaccine
Oxford scientists have initiated a Phase I trial for the ChAdOx1 BDBV vaccine to combat the Bundibugyo Ebola virus, which currently lacks approved treatments.